Lighting the Way to a Cure

  • Financials
  • Patient Library
  • Blog
  • Calendar
FSHD Header Logo
mobile-logo

  • Who We Are
        • About Us
          • History
          • Mission
          • Our Team
        • Our Impact
          • Therapeutic Accelerator
          • Education
          • Advocacy
          • Our Partners
        • Journey To A Cure
          • 2022 Donor Impact Report
  • Understanding FSHD
        • What is FSHD
          • Symptoms
          • Diagnosis
          • Early-onset FSHD
          • Genetic Testing
        • Living with FSHD
          • Newly Diagnosed?
          • Finding Care
          • Symptom Management
          • Patient Library
        • FSHD University
          • Physical Health
          • Wellness
          • Research
  • Get Involved
        • Support Us
          • Ways to Give
          • Become a Torchbearer
          • Raise Awareness
          • Volunteer
          • Fundraise
        • Advance Research
          • Patient Involvement
          • True Cost of FSHD Study
          • Clinical Trials
          • Donate tissue
        • Connect
          • Find Your Local Chapter
          • Join the Community
          • World FSHD Alliance
          • Online Communities
        • Events
          • Walk & Roll to Cure FSHD
          • Events Calendar
          • FSHD 360 Regional Conferences
          • FSHD Connect Conference
  • Research
        • For Patients & Families
          • Advance Research
          • True Cost of FSHD Study
          • TestFSHD genetic testing
          • Clinical Trials
        • For Researchers
          • Apply for a Grant
          • Research We Have Funded
          • Resources
          • Int’l Research Congress
        • For Clinicians
          • FSHD Masterclass
          • ICD-10
        • Global Collaboration
          • Therapeutic Accelerator
          • Clinical Trial Research Network
          • Drug Development Pipeline
          • Project Mercury
  • News
    • Media Library
    • Blog
      • Living with FSHD
        • Health and Medicine
        • PT and Exercise
        • Tips and Tricks
        • Mental Health
      • FSHD Society News
      • FSHD Research
      • Fundraising & Events
      • Media & PR
    • FSHD Society Radio
    • The FSHD Advocate
  • JOIN US
  • Donate
  • JOIN US
  • Donate

Genetic testing for FSHD in Asia

Home / Living with FSHD / Genetic testing for FSHD in Asia

Posted on: Sep 13, 2021

Article contributed by Pangenia.

About Pangenia Genomics

Pangenia is one of the leading diagnostic companies in Hong Kong with 15 years of experience in diagnostics and targeted treatment of hereditary diseases exemplified by neuromuscular disorders and cancers. Our diverse panel of services is well-recognized in the Asian region and beyond. The main mission of Pangenia is to provide feasible, timely and accurate diagnostic and treatment options to patients afflicted by rare diseases and to offer guidance to their families.

In 2019 we have established Pangenia Center of Excellence for Rare Diseases (PanRARE). The Center comprises key opinion and treatment leaders in the field of orphan diseases. It is the first regional venue aimed at providing patients and clinicians with a comprehensive diagnostics and treatment options for muscular dystrophies including Facioscapulohumeral Muscular Dystrophy (FSHD). PanRARE connects patients, doctors, academia, key opinion leaders, drug discovery and development enterprises and patient advocacy groups that specialize in muscular dystrophies. We collaborate with industry that actively works on developing innovative diagnostics and therapeutics for FSHD. For example, partnerships with Myocea, Inc., and Genomic Vision provide synergistic expertise in phenotypic screening, identification of biomarkers and therapeutics development in FSHD.

Molecular Testing of FSHD at PanRARE CoE

We employ the Molecular Combing™ platform to reliably diagnose FSHD1. This Genomic Morse Code technology is originally developed by Genomic Vision. The method uses specific fluorescent probes to hybridize with genomic DNA molecules (extracted from fresh blood samples) linearly stretched on coverslips (Figure 1). The fluorescent signals can then be visualized to distinguish the length (number of D4Z4 repeat units) and the type (haplotype A or B) of the D4Z4 loci (Figure 2).

Figure 1: FSHD Genomic Morse Code (GMC) Design
Figure 2: Examples of hybridization signals

To date, we have provided expeditious and rapid services to FSHD patients from both Hong Kong and Mainland China. Our team at PanRARE CoE team is happy to assist you and your loved ones with diagnostic needs.

Contact

Prospective patients are to contact Pangenia Genomics for more information on the blood sample collection and processing.

Pangenia Genomics (website)
Unit 1380, 13/F, KITEC, 1 Trademart Drive, Kowloon Bay, Hong Kong
Phone: (+852) 3989 6160  Fax: (+852) 2147 4138
Email: info@panrare.com

Monday – Saturday: 9:00am – 6:30pm, Sunday & Public holidays: Closed

Share

Filed Under: Health and Medicine, Living with FSHD

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH

Categories

  • FSHD Research
  • FSHD Society News
    • Extraordinary Measures
    • Journey to a Cure
  • Fundraising & Events
  • General
  • Living with FSHD
    • Health and Medicine
    • Mental Health
    • PT and Exercise
    • Tips and Tricks
  • Media & PR

Sign up for Email Alerts

Stay up to date with the latest FSHD news and updates from FSHD Society.

CONNECT WITH US

Proud Member World FSHD Alliance (1)
Footer-Logo-min

General Mailing Address:

75 North Main Street, Suite 1073
Randolph, MA 02368 U.S.A.

Mail Donations to:

Department 960
PO Box 4106
Woburn, MA 01888-4106

(781) 301-6060

  • DONATE
  • Donate
  • Join Us
  • Inclusivity & Equity
  • Privacy Policy
  • Contact Us
  • Glossary Of Scientific Terms
Digital Marketing by